Neihulizumab (Anti-PSGL1 / CD162)Neihulizumab (Anti-PSGL1 / CD162)
Move your mouse over image or click to enlarge

Neihulizumab (Anti-PSGL1 / CD162)

Neihulizumab (Anti-PSGL1 / CD162) is a humanized, agonistic monoclonal antibody against P selectin glycoprotein ligand-1 (PSGL-1, SELPLG, CD162) with potential immunosuppressive activity. It can halt the progression of T-cell-mediated autoimmune diseases and acute graft-versus-host disease (GvHD). MW: 150 kD.
Cat# Size Price Qty Buy
A2373-1mg*25 1mg*25
£4,152.00
A2373-1mg*5 1mg*5
£1,384.00
A2373-1mg 1mg
£441.00

Additional Information

Property Value or Rating
Manufacturer Selleck Chemicals LLC
Manufacturer Cat# A2373

Related Documents